Clobazam add-on therapy for drug-resistant epilepsy

Author:

Bresnahan Rebecca1,Martin-McGill Kirsty J12,Williamson John3,Michael Benedict D4,Marson Anthony G135

Affiliation:

1. Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Lower Lane Liverpool UK L9 7LJ

2. University of Chester; Department of Clinical Sciences and Nutrition; Faculty of Medicine, Dentistry and Life Sciences Chester UK

3. The Walton Centre NHS Foundation Trust; Liverpool UK

4. University of Liverpool; Clinical Infection Microbiology and Immunology, Institute of Infection and Global Health; 8 West Derby Street Liverpool Merseyside UK L69 7BE

5. Liverpool Health Partners; Liverpool UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference33 articles.

1. Clobazam as adjunctive treatment in refractory epilepsy;Allen;British Medical Journal,1983

2. Clobazam as an add-on drug in the treatment of refractory epilepsy of childhood;Keene;Le Journal Canadien Des Sciences Neurologiques,1990

3. Clobazam in therapy-resistant patients with partial epilepsy: a double-blind placebo-controlled crossover study;Koeppen;Epilepsia,1987

4. Clobazam for refractory focal epilepsy: a controlled trial;Schmidt;Archives of Neurology,1986

5. Andrade R Garcia-Espinosa A Machado-Rojas A Garcia-Gonzalez ME Trapaga-Quincoses O Morales-Chacon LM A prospective, open, controlled and randomised study of clobazam versus carbamazepine in patients with frequent episodes of Rolandic epilepsy Revista de Neurologia 2009 581 6

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3